Why the Clinuvel Pharmaceuticals share price is down 8% today

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has fallen over 9% today

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has fallen more than 9% during trading today. CUV shares opened at $35.57 this morning but at the time of writing, the price has dropped to $32.99, a fall of around 8.49%.

The reasons for this drop are not entirely clear, although it may involve some profit taking. At today's open price, Clinuvel shares were up 97.6% YTD, and 62% over the last three months. These price gains were likely assisted by the company's inclusion in the S&P/ASX 200 (INDEXASX: XJO) index as of 24 June.

Today's drop may also involve a delayed reaction to Clinuvel's 'communiqué', which was released to the market yesterday before opening. Clinuvel provided an update on the pending US Food and Drug Administration review of its SCENESSE (afamelanotide) product, which has been extended by three months to 6 October 2019.

Clinuvel hopes that SCENESSE (if approved) will be useful in treating erythropoietic protoporphyria (EPP), of which (according to Clinuvel) there is little effective treatment currently available to US patients, many of whom travel to Europe for treatment.

In its release, the company stated: "although the extension… for three months is not our favoured outcome, we remind all stakeholders that if insurmountable outstanding scientific issues were identified during the filing stage, and/or major deficiencies were identified during their due diligence to date, the FDA has always been able to issue a Refusal to File (RTF) and/ or recommend a withdrawal of the NDA. Since these events had not occurred, we embrace a cautious optimism and bear the patience to a long-awaited outcome."

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Woman and man calculating a dividend yield.
Share Market News

ASX market correction presents rare buying opportunities

With the All Ords in market correction territory, many quality ASX stocks look to be trading at long-term bargain levels.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A businesswoman ponders why her boat is sinking in the ocean.
Share Market News

Soaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?

After rocketing 2.4% yesterday, why is the ASX 200 crashing again today?

Read more »

Scared looking people on a rollercoaster ride representing volatility.
Opinions

Is it time to be fearful or greedy with ASX shares?

It’s a volatile time for the stock market. What should investors do?

Read more »

A fit man flexes his muscles, indicating a positive share price movement on the ASX market
Broker Notes

These 3 ASX stocks look like strong buys after the market selloff

Analysts see a lot of value in these buy-rated shares after recent volatility.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Broker Notes

Where to invest $10,000 in ASX shares after the market selloff

These shares are highly rated by analysts and could offer major upside.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Share Market News

5 things to watch on the ASX 200 on Wednesday

Volatility is expected to return today and wipe out yesterday's gains.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX roared back with a vengeance this Tuesday.

Read more »